Ian Pavelich, Ph.D., is a highly skilled scientist with extensive experience in biomolecular research and development. Currently serving as a Senior Scientist at IntegerBio since April 2025, Ian previously held roles at Tectonic Therapeutic, Inc., where contributions included advanced antibody design, implementation of high-throughput purification techniques, and management of molecular biology projects. Ian's academic background includes a Ph.D. in Biomolecular Chemistry from Emory University, complemented by leadership training from Harvard Business School Online. Early career experiences encompass significant research roles at Emory University and the Milwaukee School of Engineering, focusing on biomanufacturing and educational material development in collaboration with diverse teams.
This person is not in the org chart
This person is not in any teams
This person is not in any offices